James R. Fitterling
James R. Fitterling's purchase track record
James R. Fitterling has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/12/2024 | DOW | $1.06M | -10.6% | -23.8% | -0.1% |
| 10/29/2021 | DOW | $280K | +8.6% | +21.7% | -10.3% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Dow Inc. Announces 35¢ Quarterly Dividend Amid 43% Gain. Dow Inc. just declared a 35‑cent quarterly dividend, keeping its 5.42% yield. The stock has risen 43% this year, and Barclays has added coverage with an underweight rating and a $30 target. Analysts expect earnings growth and the company remains a dividend play for income investors. The move comes as the market dips and the stock sits near key support at $29.62.
Transaction History
| MMM | ▲ Buy | Grant | 1,360 | $195K | 5/12/2026 | View on chart |
| DOW | ▲ Buy | Grant | 60,732 | $0 | 2/12/2026 | View on chart |
| DOW | ▲ Buy | Grant | 68,230 | $0 | 2/12/2026 | View on chart |
| DOW | ▼ Sell | Other | 9,551 | $306K | 2/9/2026 | View on chart |
| MMM | ▲ Buy | Grant | 288 | $46K | 1/23/2026 | View on chart |
| DOW | ▼ Sell | Other | 1,929 | $46K | 11/28/2025 | View on chart |
| MMM | ▲ Buy | Grant | 270 | $46K | 10/24/2025 | View on chart |
| MMM | ▲ Buy | Grant | 306 | $46K | 7/23/2025 | View on chart |
| MMM | ▲ Buy | Grant | 1,297 | $195K | 5/13/2025 | View on chart |
| MMM | ▲ Buy | Grant | 333 | $46K | 4/25/2025 | View on chart |
| DOW | ▲ Buy | Grant | 58,100 | $0 | 2/13/2025 | View on chart |
| DOW | ▼ Sell | Other | 9,267 | $357K | 2/10/2025 | View on chart |
| DOW | ▲ Buy | Open Market | 14,200 | $590K | 12/12/2024 | View on chart |
| DOW | ▲ Buy | Open Market | 11,400 | $473K | 12/12/2024 | View on chart |
| DOW | ▼ Sell | Other | 1,341 | $59K | 11/29/2024 | View on chart |
| DOW | ▼ Sell | Gift | 50,135 | $0 | 9/5/2024 | View on chart |
| MMM | ▲ Buy | Grant | 1,957 | $195K | 5/14/2024 | View on chart |
| DOW | ▼ Sell | Other | 48,445 | $2.7M | 2/22/2024 | View on chart |
| DOW | ▲ Buy | Option Exercise | 50,000 | $2.3M | 2/22/2024 | View on chart |
| DOW | ▼ Sell | Other | 45,269 | $2.5M | 2/22/2024 | View on chart |
| DOW | ▲ Buy | Option Exercise | 53,487 | $2.5M | 2/22/2024 | View on chart |
| DOW | ▲ Buy | Option Exercise | 47,195 | $2.4M | 2/16/2024 | View on chart |
| DOW | ▼ Sell | Other | 44,524 | $2.5M | 2/16/2024 | View on chart |
| DOW | ▲ Buy | Option Exercise | 25,000 | $1.2M | 2/16/2024 | View on chart |
| DOW | ▼ Sell | Other | 22,711 | $1.3M | 2/16/2024 | View on chart |
| DOW | ▲ Buy | Grant | 40,380 | $0 | 2/15/2024 | View on chart |
| DOW | ▼ Sell | Other | 10,991 | $602K | 2/12/2024 | View on chart |
| DOW | ▼ Sell | Other | 44,603 | $2.4M | 2/7/2024 | View on chart |
| DOW | ▲ Buy | Option Exercise | 47,200 | $2.4M | 2/7/2024 | View on chart |
| MMM | ▲ Buy | Grant | 437 | $42K | 1/26/2024 | View on chart |
| MMM | ▲ Buy | Grant | 56 | $5K | 12/22/2023 | View on chart |
| DOW | ▼ Sell | Other | 1,162 | $60K | 11/30/2023 | View on chart |
| MMM | ▲ Buy | Grant | 381 | $34K | 10/27/2023 | View on chart |
| DOW | ▼ Sell | Gift | 14,192 | $0 | 9/15/2023 | View on chart |
| MMM | ▲ Buy | Grant | 347 | $39K | 7/28/2023 | View on chart |
| MMM | ▲ Buy | Grant | 1,808 | $185K | 5/9/2023 | View on chart |
| MMM | ▲ Buy | Grant | 320 | $34K | 4/28/2023 | View on chart |
| DOW | ▼ Sell | Other | 12,719 | $767K | 2/13/2023 | View on chart |
| DOW | ▲ Buy | Grant | 35,040 | $0 | 2/9/2023 | View on chart |
| DOW | ▲ Buy | Option Exercise | 10,998 | $520K | 2/3/2023 | View on chart |
| DOW | ▼ Sell | Other | 9,381 | $561K | 2/3/2023 | View on chart |
| MMM | ▲ Buy | Grant | 297 | $34K | 1/27/2023 | View on chart |
| DOW | ▼ Sell | Other | 1,095 | $56K | 12/2/2022 | View on chart |
| MMM | ▲ Buy | Grant | 275 | $34K | 10/28/2022 | View on chart |
| MMM | ▲ Buy | Grant | 240 | $34K | 7/29/2022 | View on chart |
| MMM | ▲ Buy | Grant | 1,214 | $185K | 5/10/2022 | View on chart |
| MMM | ▲ Buy | Grant | 229 | $34K | 4/29/2022 | View on chart |
| DOW | ▼ Sell | Gift | 16,530 | $0 | 3/2/2022 | View on chart |
| DOW | ▼ Sell | Other | 8,991 | $549K | 2/11/2022 | View on chart |
| DOW | ▲ Buy | Grant | 32,980 | $0 | 2/10/2022 | View on chart |
| DOW | ▼ Sell | Other | 1,097 | $58K | 12/3/2021 | View on chart |
| DOW | ▲ Buy | Open Market | 5,000 | $280K | 10/29/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
3M to challenge $1.4B Australian PFAS lawsuit ahead of Q3 earnings
3M is preparing to challenge Australia's $1.4 billion PFAS contamination lawsuit, a major legal development for the company. At the same time, market participants are looking ahead to 3M's upcoming third-quarter earnings, with Wall Street projections offering insights into key metrics. The stock is currently trading within its 52-week range, with an average analyst target of $186.15.
3M to challenge $1.4B Australian PFAS lawsuit ahead of Q3 earnings. 3M is preparing to challenge Australia's $1.4 billion PFAS contamination lawsuit, a major legal development for the company. At the same time, market participants are looking ahead to 3M's upcoming third-quarter earnings, with Wall Street projections offering insights into key metrics. The stock is currently trading within its 52-week range, with an average analyst target of $186.15.